跳至主要内容
临床试验/JPRN-jRCT1080221997
JPRN-jRCT1080221997未知Unknown

Post-marketing surveillance of donepezil hydrochloride -Investigation of the clinical safety and effectiveness in patients with Alzheimer's Disease

Eisai Co., Ltd.0 个研究点目标入组 1,000 人开始时间: 2013年1月9日最近更新:
适应症

试验速览

阶段
Unknown
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • Patients diagnosed as Alzheimer's Disease by DSM-IV.
  • Patients diagnosed as mild or moderate Alzheimer's Disease, applicable to FAST score 4 or 5.

排除标准

  • Patients who used Aricept within 3 months prior to dosing.
  • Patients registered this survey before.
  • Patients with a history of hypersensitivity to any ingredients of Aricept or piperidine derivatives.

研究者

相似试验